Search This Blog

Tuesday, March 16, 2021

PhaseBio target upped to $19 by Needham

 From $18; reiterates Buy.

https://finviz.com/quote.ashx?t=PHAS

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.